Literature DB >> 1695709

Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor.

I Aukhil1, C C Slemp, V A Lightner, K Nishimura, G Briscoe, H P Erickson.   

Abstract

We describe a protocol for purifying hexabrachion from conditioned medium of cell cultures, using gel filtration chromatography on Sephacryl 500, followed by anion-exchange chromatography on a Mono Q column, followed optionally by a second gel filtration or zone sedimentation on glycerol gradients. The protocol has several advantages over previous procedures based on affinity chromatography on monoclonal antibodies. Perhaps foremost, the protein is never exposed to the denaturing solvents that are required for elution from the antibody column. The Mono Q column also separated hexabrachion from a prominent cell adhesion activity that eluted with the hexabrachion on the first gel filtration, and co-sedimented with hexabrachions on glycerol gradients. The cell adhesion fractions showed several bands between 190 and 400 kDa. A single band at 220 kDa stained prominently with a polyclonal antibody against mouse EHS laminin, and a band at 190 kDa stained with a monoclonal antibody against s-laminin. The purification protocol gave hexabrachion at high concentration and with no detectable contamination by fibronectin or laminin. The highest yield of hexabrachion (1-4 mg from 400 ml of conditioned medium) was from human glioblastoma cell cultures, but the same procedure allowed us to purify and characterize the rat hexabrachion. Protein purified from primary cultures of rat embryo fibroblasts showed approximately equal amounts of three subunit sizes: 280, 230, and 220 kDa. These different subunits, presumably derived from alternative RNA splicing, appeared to be segregated into large and small hexabrachions, which could be separated on glycerol gradients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695709     DOI: 10.1016/s0934-8832(11)80176-9

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  11 in total

1.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

Authors:  C Y Chung; J E Murphy-Ullrich; H P Erickson
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

2.  Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C.

Authors:  S Denda; U Müller; K L Crossin; H P Erickson; L F Reichardt
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

3.  Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance.

Authors:  S Meiners; M L Mercado; M S Nur-e-Kamal; H M Geller
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 4.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

Review 5.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

6.  Tenascin-C Prevents Articular Cartilage Degeneration in Murine Osteoarthritis Models.

Authors:  Yuriyo Matsui; Masahiro Hasegawa; Takahiro Iino; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Akihiro Sudo
Journal:  Cartilage       Date:  2016-12-04       Impact factor: 4.634

7.  Colocalization of tenascin with versican, a hyaluronate-binding chondroitin sulfate proteoglycan.

Authors:  G Perides; H P Erickson; F Rahemtulla; A Bignami
Journal:  Anat Embryol (Berl)       Date:  1993-11

8.  Involvement of large tenascin-C splice variants in breast cancer progression.

Authors:  Takatsugu Tsunoda; Hiroyasu Inada; Ilunga Kalembeyi; Kyoko Imanaka-Yoshida; Mirei Sakakibara; Ray Okada; Koji Katsuta; Teruyo Sakakura; Yuichi Majima; Toshimichi Yoshida
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Tenascin-C suppresses Rho activation.

Authors:  M B Wenk; K S Midwood; J E Schwarzbauer
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

10.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.

Authors:  C Y Chung; H P Erickson
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.